New York State Common Retirement Fund Neuronetics, Inc. Transaction History

New York State Common Retirement Fund

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$2.09 - $3.71 $13,793 - $24,486	-6,600 Reduced 96.18%	262 $1,000
Q3 2021 Nov 02, 2021	SELL	$6.22 - $15.54 $90,426 - $225,920	-14,538 Reduced 67.93%	6,862 $45,000
Q2 2021 Aug 02, 2021	BUY	$10.15 - $17.25 $217,210 - $369,150	21,400 New	21,400 $343,000
Q2 2020 Aug 07, 2020	SELL	$1.41 - $2.61 $18,048 - $33,408	-12,800 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$9.0 - $17.2 $58,500 - $111,800	6,500 Added 103.17%	12,800 $160,000
Q4 2018 Feb 08, 2019	BUY	$16.0 - $31.84 $100,800 - $200,592	6,300 New	6,300 $122,000

13.1M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $40.8M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.